Last reviewed · How we verify
NCT06024395
A Stepped Care Approach to Treating Dental Fear
NA trial testing Dental FearLess in Dental Fear in 1,250 participants. Currently enrolling.
30 April 2028
Quick facts
| Lead sponsor | New York University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 1,250 |
| Start date | 11 September 2023 |
| Primary completion | 30 April 2028 |
| Estimated completion | 30 June 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Dental FearLess
Conditions studied
- Dental Fear — all drugs for Dental Fear →
Sponsor
New York University
Who can join
Adults 13 to 99, any sex, with Dental Fear. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to compare an intervention for dental fear to the usual approach (i.e., whatever participants' dentist typically does to help participants manage their fear). The dental fear intervention has 2 separate steps. Step 1 (the less intensive or 'light touch' intervention step) involves using a mobile application (app). Step 2 consists of a one-hour telehealth session with a mental health provider tailored to individualized dental fear. This is a randomized study. The time spent participating in the study will depend on which study condition(s) participants are randomly assigned to. Because this study compares the dental fear intervention to the standard approach, 25% of participants will not get the intervention during the study period. These participants (called controls) will be offered the opportunity to provide feedback about their experiences with dentists. Participants will be offered the intervention free of charge at the conclusion of the study. For each step of the intervention (Dental FearLess app or one-on-one session) relative to treatment as usual, the investigators hypothesize that participants will show greater declines in self-reported dental fear and improved oral health-related quality of life at post-treatment and follow-up period. De-identified attendance records will be collected from dental practices.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06024395
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dental Fear
Currently open trials in the same condition.
- NCT07462364 — The Effect of a Kaleidoscope and Cartoons for Dental Treatment in Children · NA · recruiting
- NCT07209696 — Storybook and Animation Video Adjuncts to Tell-Show-Do in Pediatric Dentistry · NA · active not recruiting
- NCT07060170 — Comparing Augmented Reality and Virtual Reality Glasses to Help Children Feel Less Pain and Anxiety During Local Anesthe · NA · recruiting
- NCT06228989 — Analysis of Treatment Outcomes in Patients Affected by Molar-Incisor Hypomineralization (MIH) · NA · active not recruiting
Other New York University trials
Trials by the same sponsor.
- NCT07526246 — Motor-based Intervention for Childhood Apraxia of Speech: DTTC-Connect · NA · not yet recruiting
- NCT07519941 — Promoting Change in Practice for Respiratory Failure · NA · not yet recruiting
- NCT07071753 — Optimizing Online Purchasing of Fruits, Vegetables, and Legumes for Low-Income Families · NA · not yet recruiting
- NCT07530900 — Prediction of Visual Feedback Effects on Speech Motor Adaptation in Healthy Adults · NA · not yet recruiting
- NCT07278934 — Testing the Impact of Family-Based Intervention to Improve Developmental and Health Outcomes for Female Adolescents · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06024395 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by New York University
- Last refreshed: 13 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06024395.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing